The Health Effects of Aluminum Compounds in Mammals

References

• Cowling E. B. Critical review: acid precipitation in historical perspective. Environ. Sci. Technol. 1982; 16: 110A
   PubMed Web of Science ®Google Scholar
• Burrows W. D. Aquatic aluminum chemistry, toxicology, and environmental prevalence. CRC Crit. Environ. Control. 1977; 7: 167
   Web of Science ®Google Scholar
• Morris T. K., Krueger G. L. The ecological effects of aluminum complexes in freshwater fish and their environments, in press
   Google Scholar
• Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. New Engl. J. Med. 1976; 294: 184
   PubMed Web of Science ®Google Scholar
• Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br. Med. J. 1977; 2: 657
   PubMed Web of Science ®Google Scholar
• Campbell I. R., Cass J. S., Cholak J., Kehoe R. A. Aluminum in the environment of man. AMA Arch. Ind. Health 1957; 15: 359
   PubMedGoogle Scholar
• Sorenson J. R. J., Campbell I. R., Tepper L. B., Lingg R. D. Aluminum in the environment and human health. Environ. Health Perspect. 1974; 8: 3
   PubMedGoogle Scholar
• Iyengar G. V., Kollmer W. E., Bowen H. J. M. The Elemental Composition of Human Tissues and Body Fluids, A Compilation of Values for Adults. Verlag Chemie, New York 1978
   Google Scholar
• King S. W., Savory J., Wills M. R. Aluminum toxicity in relation to kidney disorders. Ann. Clin. Lab. Sci. 1981; 11: 337
   PubMedGoogle Scholar
• King S. W., Savory J., Wills M. R. The clinical biochemistry of aluminum. CRC Crit. Rev. Clin. Lab. Sci. 1981; 14: 1
   Web of Science ®Google Scholar
• King S. W., Savory J., Wills M. R. Aluminum distribution in serum following hemodialysis. Ann. Clin. Lab. Sci. 1982; 12: 143
   PubMedGoogle Scholar
• Valkovic V. Is aluminum an essential element for life?. Orig. Life 1980; 10: 301
   PubMedGoogle Scholar
• International Commission on Radiological Protection, Report of the Task Group on Reference Man. Pergamon Press, Oxford 1975; 290, ICRP Publ. No. 23
   Google Scholar
• Allain P., Mauras Y. Determination of aluminum in blood, urine, and water by inductively coupled plasma emission spectrometry. Anal. Chem. 1979; 51: 2089
   PubMed Web of Science ®Google Scholar
• Shevaga V. N. Soderzhanie medi, magniya i alyuminiya v krovi i likvore zdorovy lits i bol'nykh s opukholyami golovnogo mozga razlichnoi stepeni zrelosti. Klin. Khir. 1973; 11: 80
   Google Scholar
• Ward N. I., Ryan D. E. Multi-element analysis of blood for trace metals by neutron activation analysis. Anal. Chim. Acta 1979; 105: 185
   Web of Science ®Google Scholar
• Schramel P., Wolf A., Klose B. J. Direktbestimmung von Aluminium in Serumproben mittels Inductively Coupled Plasma (ICP)-Emissions spektral-analyse. J. Clin. Chem. Clin. Biochem. 1980; 18: 591
   PubMedGoogle Scholar
• Gorsky J. E., Dietz A. A. Determination of aluminum in biological samples by atomic absorption spectrophotometry with a graphite furnace. Clin. Chem. 1978; 24: 1485
   PubMed Web of Science ®Google Scholar
• Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from antacids. New Engl. J. Med. 1977; 296: 1389
   PubMed Web of Science ®Google Scholar
• Zumkley H., Bertram H. P., Lison A., Ernst M. Oral administration of magnesium and aluminum during renal insufficiency. Trace Subst. Environ. Health 1978; 12: 248
   Google Scholar
• Salvadeo A., Minoia C., Segagni S., Villa G. Trace metal changes in dialysis fluid and blood of patients on hemodialysis. Int. J. Artif. Organs 1979; 2: 17
   PubMed Web of Science ®Google Scholar
• Bowdler N. C., Beasley D. S., Fritze E. C., Goulette A. M., Hatton J. D., Hession J., Ostman D. L., Rugg D. J., Schmittdiel C. J. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol. Biochem. Behav. 1979; 10: 505
   PubMed Web of Science ®Google Scholar
• Fuchs C., Dorn D., Doht B., Freytag E., Fuchs C. A., Henning H. V., Scheler F. Zur Aluminium-Intoxikation durch Phosphat-Binder bei Niereninsuffizienz. Verh. Dtsch. Ges. Inn. Med 1977; 83: 1313
   PubMedGoogle Scholar
• Fuchs C., Dorn D., Henning H. V., McIntosh C., Scheler F. Blutchemische Untersuchungen des Kalzium-Phosphat-Stoffwechsels. Nephrol. Klin. Prax. 1977; 4: 10
   Google Scholar
• King S. W., Wills M. R., Savory J. Serum binding of aluminum. Res. Commun. Chem. Pathol. Pharmacol. 1979; 26: 161
   PubMedGoogle Scholar
• Andersen K. J., Julshamn K., Schjoensby H. Increased serum aluminum in patients with jaundice. New Engl. J. Med. 1979; 301: 728
   PubMedGoogle Scholar
• Boukari M., Jaudon M. C., Rottembourg P. F. J., Luciani J., Legrain M., Galli A. Kinetics of serum and urinary aluminum after renal transplantation. Lancet 1978; 2: 1044
   PubMedGoogle Scholar
• Wolf A., Graf H., Pinggera W. F., Stummvoll H. K., Meisinger V. Serum aluminum and continuous ambulatory peritoneal dialysis (letter). Ann. Intern. Med. 1980; 92: 130
   PubMedGoogle Scholar
• Alderman F. R., Gitelman H. J. Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin. Chem. 1980; 26: 258
   PubMed Web of Science ®Google Scholar
• Pegon Y. Dosage d'aluminum dans les liquides biologiques par absorption atomique sans flame. Anal. Chim. Acta 1978; 101: 385
   Google Scholar
• Elliott H. L., Macdougall A. I. Aluminum studies in dialysis encephalopathy. Proc. Eur. Dial. Transplant. Assoc. 1978; 15: 157
   PubMedGoogle Scholar
• Clavel J. P., Jaudon M. C., Galli A. Dosage de l'aluminium dans les liquides biologiques par spectrophotometrie d'absorption atomique en four graphite. Ann. Biol. Clin. (Paris) 1978; 36: 33
   PubMedGoogle Scholar
• Delaney J. F. Spinal fluid aluminum levels in patients with Alzheimer disease. Ann. Neurol. 1979; 5: 580
   PubMedGoogle Scholar
• Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J. Lab. Clin. Med. 1977; 90: 810
   PubMed Web of Science ®Google Scholar
• Cam J. M., Luck V. A., Eastwood J. B., de Wardener H. E. The effect of aluminum hydroxide orally on calcium, phosphorus and aluminium metabolism in normal subjects. Clin. Sci. Mol. Med. 1976; 51: 407
   PubMedGoogle Scholar
• Gorsky J. E., Dietz A. A., Spencer H., Osis D. Metabolic balance of aluminum studied in six men. Clin. Chem. 1979; 25: 1739
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Krishnan S. S., Quittkat S. Aluminum, neurofibrillary degeneration and Alzheimer's disease. Brain 1976; 99: 67
   PubMed Web of Science ®Google Scholar
• Arieff A. I., Cooper J. D., Armstrong D., Lazarowitz V. C. Dementia, renal failure, and brain aluminum. Ann. Intern. Med. 1979; 90: 741
   PubMed Web of Science ®Google Scholar
• Le Gendre G. R., Alfrey A. C. Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate. Clin. Chem. 1976; 22: 53
   PubMedGoogle Scholar
• McDermott J. R., Smith A. I., Iqbal K., Wisniewski H. M. Brain aluminum in aging and Alzheimer disease. Neurology (Minneapolis) 1979; 26: 809
   Google Scholar
• McDermott J. R., Whitehill I. Determination of aluminum in biological tissue by flameless atomic absorption spectrometry. Anal. Chim. Acta 1976; 85: 195
   PubMedGoogle Scholar
• Alfrey A. C., Hegg A., Craswell P. Metabolism and toxicity of aluminum in renal failure. Am. J. Clin. Nutr. 1980; 33: 1509
   PubMed Web of Science ®Google Scholar
• Cammermeyer J. Argentophil neuronal perikarya and neurofibrils induced by post-mortem trauma and hypertonic perfusates. Acta Anat. Basel 1979; 105: 9
   PubMedGoogle Scholar
• Ellis H. A., Mawhinney W. H. B. Aluminium-induced dialysis osteomalacia (letter). J. Clin. Pathol. 1982; 35: 792
   PubMedGoogle Scholar
• Kushelevsky A., Yagil R., Alfasi Z., Berlyne G. M. Uptake of aluminium ion by the liver. Biomedicine (Express) 1976; 25(2)5
   Google Scholar
• Laussac J. P., Laurent J. P. Etude par resonance magnetique nucleaire (31Pet27Al) des interactions entre le nitrate d'aluminium et le triphosphate d'adenosine. C. R. Seances Acad. Sci. Ser. C 1980; 291: 157
   Google Scholar
• Wang T. S., Fawwaz R. A., Esser P. D., Jahnson P. M. Altered body distribution of (99mTc) pertechnetate in iatrogenic hyperaluminemia. J. Nucl. Med. 1978; 19: 381
   PubMedGoogle Scholar
• Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 1973; 180: 511
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Karlik S., De Boni U. Aluminum and other metals in senile (Alzheimer) dementia. Aging N.Y. 1978; 7: 471
   Google Scholar
• Yasui M., Yoshimasu F., Yase Y., Uebayashi Y. Wilson's disease: increased aluminum in liver. Folia Psychiatr. Neurol. Jpn. 1979; 33: 547
   PubMedGoogle Scholar
• Yoshimasu F., Yasui M., Yase Y., Iwata S., Gajdusek D. C., Gibbs C. J., Jr., Chen K. M. Studies on amyotrophic lateral sclerosis by neutron activation analysis. II. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases. Folia Psychiatr. Neurol. Jpn. 1980; 34: 75
   PubMedGoogle Scholar
• Stratonov V. M. Soderzhanie mikroelementov v krovi i legochnoi tkani bol'nykh aktivnym tuberkulezom legkikh. Probl. Tuberk. 1978; 5: 59
   Google Scholar
• Soroka V. R., Kats L G. Obmen mikroelementov pri khronicheskoi pnevmonii. Vrach. Delo 1977; 1: 85
   Google Scholar
• Bersudskaya S. L. Dinamika mikroelementov v krovi i moche u bol'nykh revmatoidnym artritom. Zdravookhr. Tadzh. 1977, No. 1: 22
   Google Scholar
• Arsent'evYa V., Soroka V. R., Mukhaev M. S. Khrom, alyuminii i serebro v organizme bol'nykh shizofrenii. Zh. Nevropatol. Psikhiatr. 1973; 73: 105
   PubMedGoogle Scholar
• Flendrig J. A., Kruis H., Das H. A. Aluminum intoxication, the cause of dialysis dementia?. Proc. Eur. Dial. Transplant. Assoc. 1976; 13: 355
   Google Scholar
• Sandstead H. H. Trace elements in uremia and hemodialysis. Am. J. Clin. Nutr. 1980; 33: 1051
   Google Scholar
• Womack F. C., Colowick S. P. Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 5080
   PubMed Web of Science ®Google Scholar
• Riedel B., Christensen G. Effect of selected water toxicants and other chemicals upon adenosine triphosphatase activity in vitro. Bull. Environ. Contam. Toxicol. 1979; 23: 365
   PubMed Web of Science ®Google Scholar
• Lai J. C. K., Guest J. F., Leung T. K. C., Lim L., Davison A. N. The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes. Biochem. Pharmacol. 1980; 29: 141
   PubMed Web of Science ®Google Scholar
• Sanderson C., Crapper McLachlan D. R., De Boni U. Inhibition of corticosterone bindingin vitro, in rabbit hippocampus by chromatin bound aluminum. Acta Neuropathol. 1982; 57: 249
   PubMed Web of Science ®Google Scholar
• De Boni U., Scott J. W., Crapper D. R. Intracellular aluminium binding: a histochemical study. Histochemistry 1974; 40: 31
   PubMedGoogle Scholar
• Karlik S. J., Eichhorn G. L., Lewis P. N., Crapper D. R. Interaction of aluminum species with deoxyribonucleic acid. Biochemistry 1980; 19: 5991
   PubMed Web of Science ®Google Scholar
• Bock J. L., Ash D. E. Nmr and infrared spectroscopic investigations of the Al(III), Ga(III) and Be(II) complexes of ATP. J. Inorg. Biochem. 1980; 13: 105
   Google Scholar
• Galle P. Mecanisme d'elimination renale de deux elements du groupe IIIA de la classification periodique: l'aluminium et l'indium. C. R. Acad. Sci. D (Paris) 1981; 292: 91
   Google Scholar
• Galle P., Berry J. P., Duckett S. Electron microprobe ultrastructural localization of aluminum in rat brain. Acta Neuropathol. 1980; 49: 245
   PubMedGoogle Scholar
• Galle P., Giudicelli C. P. Toxicite de l'aluminium pour l'hepatocyte: localisation ultrastructurale et micro-analyse des depots. Nouv. Presse Med. 1982; 11: 1123
   PubMedGoogle Scholar
• Fell G. S. Toxic metal exposure during medication. Proc. Nutr. Soc. 1979; 38: 263
   PubMedGoogle Scholar
• Boyce B. F., Fell G. S., Elder H. Y., Junor B. J., Elliot H. L., Beastall G., Fogelman I., Boyle I. T. Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet 1982; 2: 1009
   PubMed Web of Science ®Google Scholar
• Ott S. M., Maloney N. A., Coburn J. W., Alfrey A. C., Sherrard D. J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the responses to calcitriol therapy. New Engl. J. Med. 1982; 307: 709
   PubMed Web of Science ®Google Scholar
• Federation of American Societies for Experimental Biology, Evaluation of the health aspects of aluminum compounds as food ingredients. Life Sciences Research Office. 1975, U.S. Food and Drug Administration Service Report FDA/BF-77/24, National Technical Information Service Report No. PB-262 655
   Google Scholar
• Committee on Animal Nutrition, Mineral tolerance of domestic animals. National Research Council, National Academy of Sciences, Washington, D. C. 1980; 8
   Google Scholar
• Abrams D. E., Silcott R. B., Terry R., Berne T. V., Barbour B. H. Antacid induction of phosphate depletion syndrome in renal failure. West J. Med. 1974; 120: 157
   PubMedGoogle Scholar
• Baker L. R., Ackrill P., Cattell W. R., Stamp T. C., Watson L. latrogenic osteomalacia and myopathy due to phosphate depletion. Br. Med. J. 1974; 3: 150
   PubMedGoogle Scholar
• Dent C. E., Winter C. S. Osteomalacia due to phosphate depletion from excessive aluminum hydroxide ingestion. Br. Med. J. 1974; 1: 551
   PubMed Web of Science ®Google Scholar
• Cooke N., Teitelbaum S., Avioli L. V. Antacid-induced osteomalacia and nephrolithiasis. Arch. Intern. Med. 1978; 138: 1007
   PubMedGoogle Scholar
• Insogna K. L., Bordley D. R., Caro J. F., Lockwood D. H. Osteomalacia and weakness from excessive antacid ingestion. JAMA 1980; 244: 2544
   PubMedGoogle Scholar
• Murray R. O. Iatrogenic lesions of the skeleton. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1976; 126: 5
   Google Scholar
• Ravid M., Robson M. Proximal myopathy caused by iatrogenic phosphate depletion. JAMA 1976; 236: 1380
   PubMedGoogle Scholar
• Spencer H., Lender M. Adverse effects of aluminum-containing antacids on mineral metabolism. Gastroenterology 1979; 76: 603
   PubMed Web of Science ®Google Scholar
• Spencer H., Kramer L., Norris C., Osis D. Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism. Am. J. Clin. Nutr. 1982; 36: 32
   PubMed Web of Science ®Google Scholar
• White A., Handler P., Smith E. L., Hill R. L., Lehman I. R. Principles of Biochemistry, 6th ed. McGraw-Hill, New York 1978; 1159
   Google Scholar
• Tomimatsu Y., Donovan J. W. Spectroscopic evidence for perturbation of tryptophan in aluminum (III) and gallium (III) binding to ovotransferrin and human serum transferrin. FEBS Lett. 1976; 71: 299
   PubMedGoogle Scholar
• Gelb M. H., Harris D. C. Correlation of proton release and ultraviolet difference spectra associated with metal binding by transferrin. Arch. Biochem. Biophys. 1980; 200: 93
   PubMedGoogle Scholar
• Schroeder H. A., Mitchener M. Life-term studies in rats: effects of aluminum, barium, beryllium, and tungsten. J. Nutr. 1975; 105: 421
   PubMed Web of Science ®Google Scholar
• Schroeder H. A., Mitchener M. Life-term effects of mercury, methyl mercury, and nine other trace metals on mice. J. Nutr. 1975; 105: 452
   PubMed Web of Science ®Google Scholar
• Anderson R. J., McLikian D. M., Cambertoglio J. G., Berns A. S. P., Egan D. J., Goldberg J. P., Henrich W. L., Hicks D. L., Kovalchik M. T., Olin D. B. Prescribing medication in long-term dialysis units. Arch. Intern. Med. 1982; 142: 1305
   PubMedGoogle Scholar
• Devathasan G., Woo K. T., Pwee H. S., Tong H. I., Lim C. H. Progressive dialysis encephalopathy in Singapore: a study of 18 cases. Ann. Acad. Med. Singapore 1982; 11: 46
   PubMedGoogle Scholar
• Coburn J. W., Sherrard D. J., Brickman A. S., Wong E. G. C., Norman A. W., Singer F. R. A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to vitamin D. Contrib. Nephrol. 1980; 18: 172
   PubMedGoogle Scholar
• Coburn J. W. Renal osteodystrophy. Kidney Int. 1980; 17: 677
   PubMed Web of Science ®Google Scholar
• Cochran M., Platts M. M., Moorhead P. J., Buxton A. Spontaneous hypercalcemia in maintenance dialysis patients: an association with atypical osteomalacia and fractures. Miner. Electrolyte Metab. 1981; 5: 280
   Google Scholar
• Cournot-Witmer G., Zingraff J., Plachot J. J., Escaig F., Lefevre R., Boumati P., Bourdeau A., Garabedian M., Galle P., Bourdon R., Drueke T., Balsan S. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int. 1981; 20: 375
   PubMed Web of Science ®Google Scholar
• Emanuelli C., Borghi M., Pecchini F. Osteomalacia grave in uremico in trattamento con chelanti del fosforo in dosi eccessive, Ateneo Parmense. Acta Biomed. 1975; 46: 577
   Google Scholar
• Drueke T. Dialysis osteomalacia and aluminum intoxication. Nephron 1980; 26: 207
   PubMed Web of Science ®Google Scholar
• Cumming A. D., Simpson G., Bell D., Cowie J., Winney R. J. Acute aluminium intoxication in patients on continuous ambulatory peritoneal dialysis (letter). Lancet 1982; 1: 103
   PubMed Web of Science ®Google Scholar
• Dewberry F. L., McKinney T. D., Stone W. J. The dialysis dementia syndrome: report of fourteen cases and review of the literature. ASAIO J. 1980; 3: 102
   Google Scholar
• Pierides A. M., Frohnert P. P. Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge. Trans. Am. Soc. Artif. Intern. Organs 1981; 27: 629
   PubMedGoogle Scholar
• Mion C., Branger B., Issautier R., Ellis H. A., Rodier M., Shaldon S. Dialysis fracturing osteomalacia without hyperparathyroidism in patients treated with HCO3 rinsed Redy cartridge. Trans. Am. Soc. Artif. Intern. Organs 1981; 27: 634
   PubMedGoogle Scholar
• Pogglitsch H., Petek W., Wawschinek O., Holzer W. Treatment of early stages of dialysis encephalopathy by aluminum depletion (letter). Lancet 1981; 2: 1344
   PubMed Web of Science ®Google Scholar
• Fournier G., Gaillard J. L., Bourdon R., Drueke T. A propos d'un cas de fracture osseuse spontanee chez une patiente hemodialysee, probablement liee a la Prise orale de gels d'alumine. Nephrologie 1981; 2: 23
   PubMedGoogle Scholar
• Biswas C. K., Arze R. S., Ramos J. M., Ward M. K., Dewar J. H., Kerr D. N. S., Kenward D. H. Effect of aluminium hydroxide on serum ionised calcium, immunoreactive parathyroid hormone, and aluminium in chronic renal failure. Br. Med. J. 1982; 284: 776
   PubMedGoogle Scholar
• McKinney T. D., Basinger M., Dawson E., Jones M. M. Serum aluminum levels in dialysis dementia. Nephron 1982; 32: 53
   PubMed Web of Science ®Google Scholar
• Rotundo A., Nevins T. E., Lipton M., Lockman L. A., Mauer S. M., Michael A. F. Progressive encephalopathy in children with chronic renal insufficiency in infancy. Kidney Int. 1982; 21: 486
   PubMedGoogle Scholar
• Nathan E., Pedersen S. E. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminum hydroxide orally. Acta Paediatr. Scand. 1980; 69: 793
   PubMed Web of Science ®Google Scholar
• Geary D. F., Fennell R. S., Andriola M., Gudat J., Rodgers B. M., Richard G. A. Encephalopathy in children with chronic renal failure. J. Pediatr. 1980; 97: 41
   PubMed Web of Science ®Google Scholar
• Pillion G., Loirat C., Blum C., Poisson M., Bacri J. L., Broyer M., Mathieu H. Aluminium encephalopathy: a potential risk of aluminum gels in children with chronic renal failure. Int. J. Pediatr. Nephrol. 1981; 2: 29
   PubMedGoogle Scholar
• Barrientos A., Arteaga J., Rodicio J. L., Ude F. A., Alcazar J. M., Ruilope L. M. Role of the control of phosphate in the progression of chronic renal failure. Miner. Electrolyte Metab. 1982; 7: 127
   PubMedGoogle Scholar
• Deucher F., Nothiger F. Sterkorale Kolonperforation. Wien. Med. Wochenschr. 1980; 130(2)40
   PubMedGoogle Scholar
• Townsend C. M., Jr., Remmers A. R., Jr., Sarles H. E., Fish J. C. Intestinal obstruction from medication bezoar in patients with renal failure. New Engl. J. Med. 1973; 288: 1058
   PubMed Web of Science ®Google Scholar
• Hurley J. K. Bowel obstruction occurring in a child during treatment with aluminum hydroxide gel. J. Pediatr. 1978; 92: 592
   PubMedGoogle Scholar
• Korenman M. D., Stubbs M. B., Fish J. C. Intestinal obstruction from medication bezoars. JAMA 1978; 240: 54
   PubMed Web of Science ®Google Scholar
• Baluarte H. J., Prebis J., Goldberg M., Gruskin A. B. Metabolic alkalosis in an anephric child caused by the combined use of Kayexalate and Basaljel. J. Pediatr. 1978; 92: 237
   PubMedGoogle Scholar
• Fleming L. W., Stewart W. K., Fell G. S., Halls D. J. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium. Clin. Nephrol. 1982; 17: 222
   PubMed Web of Science ®Google Scholar
• Ackrill P., Barron J., Whiteley S., Horn A. C., Ralston A. J. A new approach to the early detection of dialysis encephalopathy. Proc. Eur. Dial. Transplant. Assoc. 1979; 16: 659
   PubMedGoogle Scholar
• Pierides A. M. Dialysis dementia, osteomalacic fractures and myopathy: a syndrome due to chronic aluminum intoxication (editorial). Int. J. Artif. Organs 1978; 1: 206
   PubMedGoogle Scholar
• Ackrill P., Ralston A. J., Day J. P., Hodge K. C. Successful removal of aluminum from patient with dialysis encephalopathy (letter). Lancet 1980; 2: 692
   PubMed Web of Science ®Google Scholar
• Adhemar J. P., Laederich J., Jaudon M. C., Masselot J. P., Galli A., Kleinknecht D. Removal of aluminum from patients with dialysis encephalopathy (letter). Lancet 1980; 2: 1311
   PubMed Web of Science ®Google Scholar
• Arze R. S., Parkinson I. S., Cartlidge N. E. F., Britton P., Ward M. K. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment (letter). Lancet 1981; 2: 1116
   PubMed Web of Science ®Google Scholar
• Platts M. M., Anastassiades E. Dialysis encephalopathy: precipitating factors and improvement in prognosis. Clin. Nephrol. 1981; 15: 223
   PubMedGoogle Scholar
• Wallace M. R. Correction of high serum aluminium in a patient on maintenance haemodialysis. N. Z. Med. J. 1981; 93: 335
   PubMedGoogle Scholar
• Graf H., Stummvoll H. K., Meisinger V. Desferrioxamine-induced ranges of aluminium kinetics during haemodialysis. Proc. Eur. Dial. Transplant. Assoc. 1981; 18: 674
   PubMedGoogle Scholar
• Bale J. F., Jr., Siegler R. L., Bray P. F. Encephalopathy in young children with moderate chronic renal failure. Am. J. Dis. Child 1980; 134: 581
   PubMedGoogle Scholar
• Hourmant M., Soulillou J. P., Boiteau H. L., Vecchierini M. F., Metayer C., Guenel J. Cinetique des taux sanguins et urinaries d'aluminium apres transplantation renale. Nephrologie 1981; 2: 125
   PubMedGoogle Scholar
• Short A. I. K., Winney R. J. Red cell indices and iron stores in patients undergoing haemodialysis (letter). Br. Med. J. 1981; 283: 562
   PubMedGoogle Scholar
• O'Hare J. A., Murnaghan D. J. Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate. New Engl. J. Med. 1982; 306: 654
   PubMed Web of Science ®Google Scholar
• Ninness J. R., Kimber R. W., McDonald J. W. Erythrocyte 2,3-DPG, ATP and oxygen affinity in hemodialysis patients. Can. Med. Assoc. J. 1974; 111: 661
   PubMedGoogle Scholar
• Bursaux E., Broyer M., Poyart C., Bohn B., Jean G. Oxygen transport in children on maintenance haemodialysis. Clin. Sci. Mol. Med. 1978; 54: 85
   PubMedGoogle Scholar
• Peserico A. Pathogenesis of porphyria cutanea tarda-like syndrome (letter). Nephron 1979; 24: 51
   PubMed Web of Science ®Google Scholar
• Sears W. G., Eales L. Aluminium-induced porphyria in the rat. IRCS Libr. Compend. 1973; 1(9)13
   Google Scholar
• Klein G. L., Alfrey A. C., Miller N. L., Sherrard D. J., Hazlet T. K., Ament M. E., Coburn J. W. Aluminum loading during total parenteral nutrition. Am. J. Clin. Nutr. 1982; 35: 1425
   PubMed Web of Science ®Google Scholar
• Baumgarten C., Kunkel G., Rudolph R., Staud R. D., Schober E., Numberger F., Hoder D., Multier A. M. Histopathological examinations of local granulomas during specific hyposensitization. Allergol. Immunopathol. (Madr.) 1978; 6: 25
   PubMedGoogle Scholar
• Bernier R. H., Frank J. A., Jr., Nolan T. F., Jr. Abscesses complicating DTP vaccination. Am. J. Dis. Child 1981; 135: 826
   PubMedGoogle Scholar
• Linse R., Hadlich J., Kirsten D. Kutane Fremdkorpergranulome durch Aluminiumhydroxid nach Desensibilisierung mit Mischpollen-Depotallergen. Dermatol. Monatsschr. 1979; 165: 653
   PubMedGoogle Scholar
• Jekel J. F., Freeman D. H., Meigs J. W. A study of trends in upper arm soft tissue sarcomas in the state of Connecticut following the introduction of alum-absorbed allergenic extract. Ann. Allergy 1978; 40: 28
   PubMedGoogle Scholar
• Clemmensen O., Knudsen H. E. Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis 1980; 6: 305
   PubMed Web of Science ®Google Scholar
• Fischer T., Rystedt I. A case of contact sensitivity of aluminum. Contact Dermatitis 1982; 8: 343
   PubMed Web of Science ®Google Scholar
• Discher D. P., Breitenstein B. D., Jr. Prevalence of chronic pulmonary disease in aluminum potroom workers. J. Occup. Med. 1976; 18: 379
   Google Scholar
• Discher D. P., Breitenstein B. D., Schweid A. I. Sputum cytology among aluminum potroom workers. Ann. N.Y. Acad. Sci. 1976; 271: 239
   PubMed Web of Science ®Google Scholar
• Clonfero E., Caroldi S., Cortese M. S., Zambon P. Problemi sanitari nei lavoratori addetti alla produzione di alluminio in un'azienda di Porto Marghera. II. La bronchite cronica. Securitas 1980; 64: 60
   Google Scholar
• Clonfero E., Caroldi S., Cortese M. S., Zambon P. Problemi sanitari nei lavoratori addetti alla produzione di alluminio in un'azienda di Porto Marghera. III. La pneumoconiosi da allumina. Securitas 1980; 64: 63
   Google Scholar
• Cataldi R., De Palma M., Valente T., Bonsignore A. D. Su du casi di fibrosi polmonare da ossido di alluminio. Med. Lav. 1981; 72: 318
   PubMedGoogle Scholar
• Saia B., Cortese S., Piazza G., Camposampietro A., Clonfero E. Chest X-ray findings among aluminium production plant workers. Med. Lav. 1981; 72: 323
   PubMedGoogle Scholar
• Szczekocki W., Chmielewski J., Uselis J., Taniewski M. Estimation of the professional exposure of persons employed at reloading of aluminum oxide. II. Bull. Inst. Mar. Med. Gdansk. 1973; 24(3)211
   Google Scholar
• Szczekocki W., Chmielewski J. Ocena drog wchlaniania i wydalania glinu u osob narazonych na zawodowy kontaki z tlenkiem glinu. Pol. Tyg. Lek. 1977; 32(18)683
   PubMedGoogle Scholar
• Szczekocki W., Chmielewski J. Indexes of the occupational exposure to aluminum oxide dusts. Bull. Inst. Marit. Trop. Med. Gdynia 1978; 29(1–2)37
   PubMedGoogle Scholar
• Renke W., Chmielewski J. Blood coagulation and fibrinolysis system in occupational exposure to some chemical factors. Bull. Inst. Marit. Trop. Med. Gdynia 1976; 27(3–4)289
   PubMedGoogle Scholar
• Pelfini C., Jucci A., Vignini M., Catenacci S. Patologia locale e generale da ustioni da alluminio, a proposito di due casi. Chron. Dermatol. 1977; 8: 451
   Google Scholar
• Valentin H., Preusser P., Schaller K. H. Die Analyse von Aluminium in Serum und Urin zur Ubewachung exponierter Personen. Int. Arch. Occup. Environ. Health 1976; 38: 1
   PubMedGoogle Scholar
• U.S. Department of Labor, Occupational Safety and Health Administration. OSHA Safety and Health Standards, revised ed. U.S. Government Printing Office, Washington, DC 1981
   Google Scholar
• Documentation of the Threshold Limit Values, 4th ed. American Conference of Governmental Industrial Hygienists. 1980. ACGIH, Cincinnati 1980
   Google Scholar
• Stotland L. M., Share N. N. Active bronchial anaphylaxis in the rat. Can. J. Physiol. Pharmacol. 1974; 52: 1114
   PubMedGoogle Scholar
• Velasco M., Velasco F., Estrada-Villaneuva F., Oivera A. Alumina cream-induced focal motor epilepsy in cats. I. Lesion size and temporal course. Epilepsia 1973; 14: 3
   PubMedGoogle Scholar
• Selkoe D. J., Liem R. K., Yen S. H., Shelanski M. L. Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degenertion induced by aluminium. Brain Res. 1979; 163: 235
   PubMedGoogle Scholar
• Wisniewski H. M., Sturman J. A., Shek J. W. Aluminum chloride induced neurofibrillary changes in the eveloping rabbit a chronic animal model. Ann. Neurol. 1980; 8: 479
   PubMed Web of Science ®Google Scholar
• Shalimov A. D., Medvetsky E. B., Keisevich L. V. Mechanizmy metaplazii protovogo epiteliya organov pankreato-biliarnoi sistemy. Biull. Eksp. Biol. Med. 1981; 92(7)112
   PubMedGoogle Scholar
• Krasovskii G. N., Vasukovich L. Y., Chariev O. G. Experimental study of biological effects of lead and aluminum following oral administration. Environ. Health Perspect. 1979; 30: 47
   PubMed Web of Science ®Google Scholar
• Adamson R. H., Canellos G. P., Sieber S. M. Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. Cancer Chemother. Rep. 1975; 59: 599
   PubMedGoogle Scholar
• Martin J. C., Daniel H., Le Bouffant L. Etude de l'action therapeutique du chlorhydroxyallantoinate d'aluminium sur la silicose experimentale du rat. Arch. Mal. Prof. Med. Trav. Secur. Soc. 1979; 40: 63
   Google Scholar
• Magour S., Maser H. Differential effects of intraperitoneal and oral administration of aluminium on brain ribosomal protein synthesis of mature and immature rats. Organ-Directed Toxicity, Chemical Indices and Mechanisms, S. S. Brown, D. S. Davies. Pergamon Press, New York 1981; 257
   Google Scholar
• Lewkowski J. P., Malanchuk M., Hastings L., Vinegar A., Cooper G. P. Effects of chronic exposure of rats to automobile exhaust, sulfuric acid, sulfur dioxide, aluminum sulfate, and carbon monoxide. Assessing Toxic Effects of Environmental Pollution, S. D. Lee, J. B. Brian. Ann Arbor Scientific, Ann Arbor, Mich. 1979; 187
   Google Scholar
• Drew R. T., Gupta B. N., Bend J. R., Hook G. E. R. Inhalation studies with a glycol complex of aluminium chloride hydroxide. Arch. Environ. Health 1974; 28: 321
   PubMed Web of Science ®Google Scholar
• Steinhagen W. H., Cavender F. L., Cockrell B. Y. Six month inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. J. Environ. Pathol. Toxicol. 1978; 1: 267
   PubMedGoogle Scholar
• Stone C. J., McLaurin D. A., Steinhagen W. H., Cavender F. L., Haseman J. K. Tissue deposition patterns after chronic inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. Toxicol. Appl. Pharmacol. 1979; 49: 71
   PubMed Web of Science ®Google Scholar
• Gross P., Harley R. A., Jr., De Treville R. T. P. Pulmonary reaction to metallic aluminum powders: an experimental study. Arch. Environ. Health 1973; 26: 227
   PubMed Web of Science ®Google Scholar
• Sackner M. A., Dougherty R. L., Chapman G. A., Cipley J., Perez D., Kwoka M., Reinhart M., Brito M., Schreck R. Effects of brief and intermediate exposures to sulfate submicron aerosols and sulfate injections on cardiopulmonary function of dogs and tracheal mucous velocity of sheep. J. Toxicol. Environ. Health 1981; 7: 951
   PubMed Web of Science ®Google Scholar
• Pigott G. H., Gaskeli B. A., Ishmael J. Effects of long term inhalation of alumina fibres in rats. Br. J. Exp. Pathol. 1981; 62: 323
   PubMedGoogle Scholar
• Rylander R., Sjostrand M., Bergstrom R. Free lung cell response after combined exposure to cigarette smoke and industrial dusts. Toxicology 1979; 12: 211
   PubMedGoogle Scholar
• Domnin S. G., Aronova G. V., Fomina A. S. O mekhanisme povrezhdayushchego deistviya soedinenii alyuminiya. Gig. Tr. Prof. Zabol. 1980; 5: 20
   Google Scholar
• Leininger J. R., Farrell R. L., Johnson G. R. Acute lung lesions due to ziriconium and aluminum compounds in hamsters. Arch. Pathol. Lab. Med. 1977; 101: 545
   PubMedGoogle Scholar
• Fritsch P., Masse F. Etude de la migration des leucocytes vers le milieu endoalveolaire. C. R. Acad. Sci. 1979; 288: 1607
   Google Scholar
• Henry M. C., Kaufman D. G. Clearance of benzo(a) pyrene from hamster lungs after administration on coated particles. J. Natl. Cancer Inst. 1973; 51: 1961
   PubMedGoogle Scholar
• Ehm W. Beziehungen der Oxiprolinkonzentration in Lungen zum Lungengewicht, zu Kieselsaure-und Aluminiumkonzentrationen sowie zur Staubdosis nach Widerholter Intratrachealer Kohlenstaubapplikation im Langzeitversuch an Ratten. Staub-Reinhalt. Luft. 1976; 36: 410
   Google Scholar
• Rosmanith J., Backheurer D., Bianchi P., Molls I. Verlauf der Elimination aus Lunge und Leber von Eisen, Zink, Kieselsaure und Aluminium Nach Wiederholter Intratrachealer Kohlenstaubapplikation (Tierversuche). Beitr. Silikoseforsch. 1975; 27(2)45
   Google Scholar
• Rosmanith J.D. Prajsnar, Ehm W. Das Verhalten der Lipide und des Aluminiums im Lungenparenchym der Ratten nach Intratrachealer Kohlenstaub-applikation. Staub-Reinhalt. Luft 1977; 37(2)61
   Google Scholar
• Marquis J. K. Aluminum neurotoxicity: an experimental perspective. Bull. Environ. Contam. Toxicol. 1982; 29: 43
   PubMedGoogle Scholar
• Commissaris R. L., Cordon J. J., Sprague S., Keiser J., Mayor G. H., Rech R. H. Behavioral changes in rats after chronic aluminium and parathyroid hormone administration. Neurobehav. Toxicol. Teratol. 1982; 4: 403
   PubMedGoogle Scholar
• Valdivia R., Ammermann C. B., Henry P. R., Feaster J. P., Wilcox C. J. Effect of dietary aluminum and phosphorus on performance, phosphorus utilization and tissue mineral composition in sheep. J. Anim. Sci. 1982; 55: 402
   PubMed Web of Science ®Google Scholar
• Allen V. G., Robinson D. L. Occurrence of aluminum and manganese in grass tetany cases and their effects on solubility of calcium and magnesium. in vitro, Agron. J. 1980; 72: 957
   Web of Science ®Google Scholar
• Von Herrath D., Kraft D., Schaefer K., Krempien B. Experimental uremic osteodystrophy and its treatment. Proc. Workshop Vitam. D Probl. Relat. Uremic Bone Dis. 1975; 585
   Google Scholar
• Von Herrath D., Schaefer K., Krempien B. The influence of uremia, aluminium hydroxide and various vitamin D compounds on the course of nutritional rickets in rats. Proc. Workshop Vitam. D. 1979; 893
   Google Scholar
• Schneider H. J., Unger G., Rossler D., Bothor C., Berg W., Ernst G. Der Einfluss verschiedener in der Harnsteinmetaphylaxe verwendeter Medikamente auf das Wachstum und den Stoffwechsel junger Versuchstiere. Z. Urol. Nephrol. 1979; 72: 237
   PubMedGoogle Scholar
• Fuller T. J., Carter N. W., Barcenas C., Knochel J. P. Reversible changes of the muscle cell in experimental phosphorus deficiency. J. Clin. Invest. 1976; 57: 1019
   PubMed Web of Science ®Google Scholar
• Ganelina I. E., Deryagina G. P., Sinitsyna T. A., Astashkina N. A., Egorova E. M. Vliyanie alyuminiya na razvitie eksperimental'nogo ateroskleroza. Kardiologiya 1979; 19(5)110
   Google Scholar
• Ellis H. A., McCarthy J. H., Herrington J. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J. Clin. Pathol. 1979; 32: 832
   PubMed Web of Science ®Google Scholar
• Lansdown A. B. Production of epidermal damage in mammalian skins by some simple aluminium compounds. Br. J. Dermatol. 1973; 89: 67
   PubMed Web of Science ®Google Scholar
• Kang K. Y., Bice D., Hoffmann E., D'Amato R., Salvaggio J. Experimental studies of sensitization to beryllium, zirconium, and aluminum compounds in the rabbit. J. Allergy Clin. Immunol. 1977; 59: 425
   PubMed Web of Science ®Google Scholar
• Frati C., Fiorentini G. Rilievi istochimici, morfologici e biologici nel topo trattato localmente con sali di alluminio. Ann. Ital. Derm. Clin. Sper. 1974; 28: 375
   Google Scholar
• Griss P., Werner E., Buchinger R., Busing C. M., Heimke G. Zur Frage der Unspezifischen Sarkomentstehung um Al2O3-Keramische Implantate. Experimentelle Untersuchungen. Arch. Orthop. Un-fall-Chir. 1977; 90: 29
   Google Scholar
• Greenberg S. R. The pulmonary effects of pure aluminum. Bull. Soc. Pharmacol. Environ. Pathol. 1977; 5(4)8
   Google Scholar
• McNamara A., Williams D. F. The response to the intramuscular implantation of pure metals. Biomaterials 1981; 2: 33
   PubMed Web of Science ®Google Scholar
• McNamara A., Williams D. F. Scanning electron microscopy of the metal-tissue interface. II. Observations with lead, copper, nickel, aluminum, and cobalt. Biomaterials 1982; 3: 165
   PubMedGoogle Scholar
• Le Bouffant L., Daniel H., Martin J. C. The therapeutic action of aluminium compounds on the development of experimental lesions produced by pure quartz or mixed dust. Inhaled Particles, W. H. Walton, B. McGovern. Pergamon Press, New York 1977; Vol. 4: 389, Part 1
   Google Scholar
• Ehrlich R. Interaction between environmental pollutants and respiratory infections. Environ. Health Perspect. 1980; 35: 89
   PubMed Web of Science ®Google Scholar
• Hatch G. E., Slade R., Boykin E., Hu P. C., Miller F. J., Gardner D. E. Correlation of effects of inhaled versus intratracheally injected metals on susceptibility to respiratory infection in mice. Am. Rev. Respir. Dis. 1981; 124: 167
   PubMed Web of Science ®Google Scholar
• Pigott G. H., Ishmael J. An assessment of the fibrogenic potential of two refractory fibres by intraperitoneal injection in rats. Toxicol. Lett. 1981; 8: 153
   PubMed Web of Science ®Google Scholar
• Stanton M. F. Fiber carcinogenesis: is asbestos the only hazard? (editorial). J. Natl. Cancer Inst. 1974; 52: 633
   PubMedGoogle Scholar
• MacFarlane J. O. An objective appraisal of the safety of the aluminum and oil adjuvants with regard to their potential for oncogenic action. 1974, Food and Drug Administration Report FDA-BF-75-2, National Technical Information Service Report No. PB-240 114
   Google Scholar
• Sellakumar A., Stenback F., Rowland J. Effects of different dusts on respiratory carcinogenesis in hamsters induced by benzo(a) pyrene and diethylnitrosamine. Eur. J. Cancer 1976; 12: 313
   PubMedGoogle Scholar
• Stenback F. G., Ferrero A., Shubik P. Synergistic effects of diethylnitrosamine and different dusts on respiratory carcinogenesis in hamsters. Cancer Res. 1973; 33: 2209
   PubMed Web of Science ®Google Scholar
• Stenback F., Rowland J., Sellakumar A. Carcinogenicity of benzo(a)-pyrene and dusts in the hamster lung (instilled intracheally with titanium oxide, aluminum oxide, carbon and ferric oxide). Oncology 1976; 33: 29
   PubMed Web of Science ®Google Scholar
• Pfeiffer E. H. Investigations on the carcinogenic burden by air pollution in man. XI. About the effect of aluminium hydroxide upon the benzo(a) pyrene carcinogenesis. Zentrabl. Bakteriol. (B) 1975; 160: 99
   PubMedGoogle Scholar
• Wagner J. C., Berry G., Timbrell V. Mesotheliomata in rats after inoculation with asbestos and other materials. Br. J. Cancer 1973; 28: 173
   PubMed Web of Science ®Google Scholar
• Maltoni C., Minardi F., Morisi L. Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence. Environ. Res. 1982; 29: 238
   PubMed Web of Science ®Google Scholar
• Yamane Y., Ohtawa M. Possible mechanism of suppressive action of aluminum chloride on lung carcinogenesis in mice induced by 4-nitroquinoline 1-oxide. II. Effect of aluminum chloride on metabolism of 4-nitroquinoline 1-oxide. Gann 1979; 70: 147
   PubMedGoogle Scholar
• Sunderman F. W., Lau T. J., Cralley L. J. Inhibitory effect of manganese upon muscle tumorigenesis by nickel subsulfide. Cancer Res. 1974; 34: 92
   PubMed Web of Science ®Google Scholar
• Marretta J., Casey F. B. Dependence of the guinea pig IgE and IgG1 immune responses on the inclusion of potassium in the preparation of alum adjuvant. J. Immunol. Methods 1979; 32: 183
   Google Scholar
• Speirs R., Knowles B. J., Takenaka T. Effect of chemicals in IgE antibody and eosinophil cell responses to tetanus toxoid in the mouse. Inadvertent Modification of the Immune Response, The Effects of Foods, Drugs, and Environmental Contaminants, I. M. Asher, U. S. Naval, 1980; 80, Acad., U.S. HHS Publ. No. Proc. 4th FDA Sci. Symp.
   Google Scholar
• Tanaka A., Ishibashi T., Kohashi O., Koga T., Sugiyama K. The mode of action of immunological adjuvants. I. A new method to assess the adjuvant effect of substances as represented by mycobacterial adjuvants. Jpn. J. Exp. Med. 1975; 45(3)139
   PubMedGoogle Scholar
• Vassilev T. L. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy 1978; 33(3)155
   PubMedGoogle Scholar
• Vijay H. M., Lavergne G., Huang H., Berstein I. L. Preferential synthesis of IgE reaginic antibodies in rats immunized with alum-adsorbed antigens. Int. Arch. Allergy Appl. Immunol. 1979; 59: 227
   PubMedGoogle Scholar
• Chiorazzi N., Tung A. S., Katz D. H. Hapten-specfic IgE antibody responses in mice. J. Immunol. 1979; 122: 1495
   PubMedGoogle Scholar
• Pauwels R., Bazin H., Platteau B., Van Der Straeten M. The influence of different adjuvants on the production of IgE and IgE antibodies. Ann. Immunol. Paris 1979; 130C: 49
   PubMedGoogle Scholar
• Hanna N., Nelken D. The effect of adjuvant induced suppressor cells on in vitro and in vivo lymphocyte responses. Adv. Exp. Med. Biol. 1979; 114: 351
   PubMedGoogle Scholar
• Hanna N., Blanc S., Nelken D. Adjuvant-induced nonspecific suppressor cells:in vitroin vivo studies. Cell Immunol. 1980; 53: 225
   PubMedGoogle Scholar
• Leech S. H., Ali M. Low-dose restriction in Ir-gene control reflects susceptibility to tolerance induction. Cell Immunol. 1981; 64: 350
   PubMedGoogle Scholar
• Kada T., Hirano K., Shirasu Y. Screening of environmental chemical mutagens by the rec-assay system withBacillus subtilis. Chemical Mutagens, Principles and Methods for Their Detection, F. J. de Serres, A. Hollaender. Plenum Press, New York 1980; Vol. 6: 739
   Google Scholar
• Kanematsu N., Hara M., Kada T. Rec-assay and mutagenicity studies on metal compounds. Mutat. Res. 1980; 77: 109
   PubMed Web of Science ®Google Scholar
• Litton Bionetics, Inc. Mutagenic evaluation of sodium aluminum phosphate. 1975, U.S. Food and Drug Administration Report FDA/HFF-76/80, National Technical Information Service Report No. PB-254 520
   Google Scholar
• Litton Bionetics, Inc. 1977, Mutagenicity evaluation of FDA 75–91, aluminum potassium sulfate, U.S. Food and Drug Administration Report FDA/BF-78/57, National Technical Information Service Report No. PB-278 461
   Google Scholar
• Brown J. P., Dietrich P. S., Bakner C. M. Mutagenicity testing of some drug and cosmetic dye lakes with the Salmonella/mammalian microsome assay. Mutat. Res. 1979; 66: 181
   PubMed Web of Science ®Google Scholar
• Oberly T. J., Piper C. E., McDonald D. S. Mutagenicity of metal salts in the L5178Y mouse lymphoma assay. J. Toxicol. Environ. Health. 1982; 9: 367
   PubMed Web of Science ®Google Scholar
• Tan E. L., Hsie A. W. Effect of calcium phosphate and alumina C gels on the mutagenicity and cytotoxicity of dimethylnitrosamine as studied in the HCO/HGPRT system. Mutat. Res. 1981; 84: 147
   PubMedGoogle Scholar
• Casto B. C., Meyers J., Di Paolo J. A. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts. Cancer Res. 1979; 39: 193
   PubMed Web of Science ®Google Scholar
• Di Paolo J. A., Casto B. C. Quantitative studies ofin vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res. 1979; 39: 1008
   PubMed Web of Science ®Google Scholar
• Sirover M. A., Loeb L. A. Infidelity of DNA synthesisin vitro: screening for potential metal mutagens of carcinogens. Science 1976; 194: 2434
   Google Scholar
• Sunderman F. W., Jr. Carcinogenic effects of metals. Fed. Proc. 1978; 37: 40
   PubMedGoogle Scholar
• Chamberlain M., Brown R. C., Davies R., Griffiths D. M. prediction of the pathogenicity of mineral dusts. Br. J. Exp. Pathol. 1979; 60: 320
   PubMed Web of Science ®Google Scholar
• Aranyi C., Bradof J., Gardner D. E., Huisingh J. L. In vitroin vivo evaluation of potential toxicity of industrial particles. Environ. Sci. Res. 1981; 22: 431
   Google Scholar
• Hahon N., Booth J. A., Pearson D. J. Inhibition of viral interferon induction in mammalian cell monolayers by metallic copper, aluminum and nickel particles. The In Vitro Effects of Mineral Dusts, R. C. Brown, M. Chamberlain, R. Davies. Academic Press, London 1980; 219
   Google Scholar
• Adamis Z., Timar M. Effects of various mineral dusts on macrophagesin vitro. Int. Arch. Occup. Environ. Health 1976; 37: 301
   PubMedGoogle Scholar
• Turk J. L. Immunologic and nonimmunologic activation of macrophages. J. Invest. Dermatol. 1980; 74: 301
   PubMed Web of Science ®Google Scholar
• Kang K. Y., Salvaggio J. Effects of zirconium and aluminum salts on the alveolar macrophages. Tohoku J. Exp. Med. 1978; 126: 317
   PubMedGoogle Scholar
• Kang K. Y., Salvaggio J. Effects of zirconium and aluminum salts on the alveolar macrophages. Tohoku J. Exp. Med. 1978; 126: 317
   PubMedGoogle Scholar
• Ramanathan V. D., Badenoch-Jones P., Turk J. L. Complement activation by aluminium and zirconium compounds. Immunology 1979; 37: 881
   PubMed Web of Science ®Google Scholar
• Camner P., Lundborg M., Hellstrom P. A. Alveolar macrophages and 5 m particles coated with different metals.In vitro studies. Arch. Environ. Health 1974; 29: 211
   Web of Science ®Google Scholar
• Castranova V., Bowman L., Miles P. R., Reasor M. J. Toxicity of metal ions to alveolar macrophages. Am. J. Ind. Med. 1980; 1: 349
   PubMedGoogle Scholar
• Bonhaus D. W., McCormack K. M., Mayor G. H., Mattson J. C., Hook J. B. The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol. Lett. 1980; 6: 141
   PubMed Web of Science ®Google Scholar